These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3365924)

  • 21. [Effectiveness and adverse effects of a single daily dose of gentamicin versus twice daily administration].
    Puljević D; Gasparović V
    Lijec Vjesn; 1995; 117(1-2):33-8. PubMed ID: 7651068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid colorimetric assay for gentamicin injection.
    Tarbutton P
    Am J Hosp Pharm; 1987 Jan; 44(1):115-20. PubMed ID: 3826084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a controlled-released membrane infusion device for delivery of gentamicin.
    Nahata MC; Durrell DE; Miller MA
    Chemotherapy; 1990; 36(1):8-12. PubMed ID: 2307027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osmolality of small-volume intravenous admixtures.
    Wermeling DP; Rapp RP; DeLuca PP; Piecoro JJ
    Am J Hosp Pharm; 1985 Aug; 42(8):1739-44. PubMed ID: 4036971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.
    Lesko LJ; Marion A; Ericson J; Siber GR
    Am J Hosp Pharm; 1981 Jul; 38(7):1004-6. PubMed ID: 7258196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of tobramycin pharmacokinetics after administration by CRIS and a traditional intravenous piggyback infusion.
    Mauro VF; Jacobs LR; Mauro LS; MacArthur RD; White DB
    Ann Pharmacother; 1995 May; 29(5):465-9. PubMed ID: 7655128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesoporous SBA-15 HPLC evaluation for controlled gentamicin drug delivery.
    Doadrio AL; Sousa EM; Doadrio JC; Pérez Pariente J; Izquierdo-Barba I; Vallet-Regí M
    J Control Release; 2004 May; 97(1):125-32. PubMed ID: 15147810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single and multiple dose pharmacokinetics of gentamicin administered intravenously and intramuscularly in adult conditioned thoroughbred mares.
    Swan GE; Guthrie AJ; Mülders MS; Killeen VM; Nurton JP; Short CR; van den Berg JS
    J S Afr Vet Assoc; 1995 Sep; 66(3):151-6. PubMed ID: 8596186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug disposition and dosage determination of once daily administration of gentamicin sulfate in horses after abdominal surgery.
    Tudor RA; Papich MG; Redding WR
    J Am Vet Med Assoc; 1999 Aug; 215(4):503-6. PubMed ID: 10461634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of a high dose of gentamicin administered intravenously or intramuscularly to horses.
    Magdesian KG; Hogan PM; Cohen ND; Brumbaugh GW; Bernard WV
    J Am Vet Med Assoc; 1998 Oct; 213(7):1007-11. PubMed ID: 9776999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of delivery of cefazolin, chloramphenicol, and vancomycin by a controlled-release membrane infusion device.
    Nahata MC; Durrell DE; Miller MA
    Am J Hosp Pharm; 1988 Nov; 45(11):2358-60. PubMed ID: 3228092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of drug delivery dynamics via a pediatric central venous infusion system: quantification of delays in achieving intended doses.
    Bartels K; Moss DR; Peterfreund RA
    Anesth Analg; 2009 Oct; 109(4):1156-61. PubMed ID: 19762743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of mitomycin admixtures.
    Quebbeman EJ; Hoffman NE; Ausman RK; Hamid AA
    Am J Hosp Pharm; 1985 Aug; 42(8):1750-4. PubMed ID: 4036973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of analytical inaccuracy on dose adjustment for gentamicin using the Abbottbase Pharmacokinetic Systems.
    Bouzas L; Hermida J; Tutor JC
    Clin Lab; 2004; 50(3-4):187-91. PubMed ID: 15074474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating a filter device used for intermittent intravenous drug delivery to newborn infants.
    Koren G; Rajchgot P; Harding E; Perlman M; MacLeod SM
    Am J Hosp Pharm; 1985 Jan; 42(1):106-8. PubMed ID: 3970024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pathological evaluation of gentamicin in cats given a small intravenous dose repeatedly for five days.
    Jernigan AD; Hatch RC; Brown J; Crowell WA
    Can J Vet Res; 1988 Apr; 52(2):177-80. PubMed ID: 3370552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of DepoFoam gentamicin delivery system and effect on soft tissue infection.
    Grayson LS; Hansbrough JF; Zapata-Sirvent RL; Kim T; Kim S
    J Surg Res; 1993 Nov; 55(5):559-64. PubMed ID: 8231176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
    Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
    Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting drug delivery from a syringe-pump infusion set.
    Geater RE; Leff RD; Roberts RJ
    Am J Hosp Pharm; 1985 Nov; 42(11):2510-3. PubMed ID: 4073070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.